2 completed, 1 terminated, 1 withdrawn. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
Follow conivaptan: new trials by email Literature Review of conivaptan trials Research Report on conivaptan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients Conivaptan, Placebo (Dextrose) - Heart Failure | Phase 4 | Completed | Finn Gustafsson | 20 | 2013-12-01 | 2015-06-17 |
| Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion Conivaptan, Placebo - Heart Failure | Phase 4 | Withdrawn | Albert Einstein Healthcare Network | 2008-10-01 | 2011-06-23 | |
| Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients Conivaptan - Hyponatremia | Phase 4 | Terminated | Northwestern University | 6 | 2008-08-01 | 2022-03-28 |
| A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia Conivaptan, placebo - Hyponatremia, Euvolemia | Phase 4 | Completed | Cumberland Pharmaceuticals | 121 | 2007-01-01 | 2014-05-15 |
Heart Failure (2) · Hyponatremia (2) · Diabetes Insipidus (1) · Edema (1)
Albert Einstein Healthcare Network (1) · Cumberland Pharmaceuticals (1) · Finn Gustafsson (1) · Northwestern University (1)
Denmark (1) · India (1) · Israel (1) · United States (1)
Andrew M Naidech, MD, MSPH (1) · Art Wheeler, MD (1) · Darshak H Karia, MD (1) · Finn Gustafsson, MD, PhD, DMSci (1) · Louise Balling, MD (1)